The aim of this research was to determine the cytotoxic action of sixteen structurally-related eremophilane-type sesquiterpenes, isolated from several species of Senecio, against a panel of cancer cell lines. The cytotoxic activities were evaluated by WST-1 test and the IC50 values calculated. The investigated compounds exerted dose-dependent cytotoxic actions against selected cancer cell lines and no-tumoral HS5 cell line. The comparative structure-activity relationships demonstrated the importance of C-1, C-6, and C-8 substituents in the molecule. Our results show that eremophilane-type sesquiterpenes may represent an important source of novel potential antitumor agents due to their pronounced cytotoxic actions towards malignant cells.
Natural products are a rich source of compounds with promising cancer therapeutic potential, such as vinca alkaloids, taxanes, campothecins, etc. [1] . Sesquiterpenes represent a group of natural compounds with diverse skeletal types. Among them, the eremophilane-type sesquiterpenes, including eremophilanes, furanoeremophilanes, eremophilanolides and secoeremophilanolides, are widely present in several genera of Asteraceae (such as Cacalia, Ligularia, Petasites, Senecio) [2] and fungi [3] , and are biosynthetically differently from other sesquiterpenes. These compounds have a number of biological activities such as antitumor, anti-bacterial and anti-inflammatory among others [2b] .
In Senecio species, furanoeremophilanes and eremophilanolides are the most frequently isolated sesquiterpene skeletons [2, 4] . As part of our ongoing studies on bioactive sesquiterpenes from Senecio species, sixteen structurally-related eremophilanolides have been tested against a panel of tumoral cell lines and their structure activity relationships (SAR) studied.
The cytotoxicity of the test compounds on several tumoral (MCF7, A549, H292, HCT116, HeLa, SKMEL5, and DU145) and nontumoral (HS5) cell lines compared to that of two usual drugs in clinical practice (cisplatin and paclitaxel) is shown in Table 1 .
The eremophilanolides tested here inhibited the celular growth in a dose-dependent manner (Table 1) . HS5 and HCT116 cell lines were the most sensitive followed by A549 and SKMEL5 cell lines. H292 cell line was the most resistant. Compound 1 was the most active for all cell lines tested. The cytotoxic effects of compound 2 were also remarkable. In general, the activity of these two compounds was superior to that of cisplatin and paclitaxel.
The cytotoxic activity of eremophilanolides from Ligularia sp. [3e, 5] and Calomeria amaranhoides [6] has been described. However, this is the first report on the cytotoxic effects of eremophilanolides 1-16 from Senecio sp. Table 2 shows the SAR of compounds 1-16. The most active eremophilanolides were found in the 1,8 substituted group and had a β-OMe at C-8 in their moiety (1, 2). Among the 1,10 unsaturated group of terpenes, the presence of an α-OMe at C-8 resulted in the most active compounds (3, 4), followed by 5 and 6 with the bulkiest substituents at C-6. The least active group was the 1,10 epoxide, however it is interesting to note that the activity depended on the epoxide stereochemistry (14, β-epox) ( Table 2) . (Table 1) .
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Therefore, the substitution pattern at C-1, C-6, and C-8 of eremophilanolides resulted in tumor-selective cytotoxicity against human tumor cell lines. This would be an important biological structural requirement and could provide new rational basis for the design of new antitumor compounds.
In summary, the most interesting eremophilanoides were 1 and 2, due to their high cytotoxic activity against the panel of tumor cell lines tested. The cytotoxicity of these compounds showed dose-and cell line-dependent effects, with IC50 lowers of those of CDDP and PTX. The comparative structure-activity relationships showed the importance of C-1, C-6, and C-8 substituents in the molecule.
Experimental
Compounds: Compounds 3, 10 and 11 were isolated from S. magellanicus [7] ; 1, 2 and 9 from S. kingii [8] ; 8 from S. miser [9] and compound 7 from S. poepigii [10] . Compounds 4, 14-16 are derivatives of 3 and 12 is an acetylated derivative of 10 [7] .
Compounds 5, 6 and 13 have been isolated from S. bollei collected in Lanzarote (Canary Islands), (Voucher number ORT32501. Centro de Investigaciones y Tecnología Agraria, Tenerife). Dried aerial parts of S. bollei (1.6 Kg) were extracted with EtOH in a Soxhlet. The ethanolic extract (122 g, 7.62% yield of dry plant weight) was chromatographed on a silica gel vacuum liquid chromatography (VLC) column using an n-hexane-EtOAc-MeOH gradient, to give six fractions. All fractions were further chromatographed on a Si gel column and /or by preparative normalphase HPLC on a Inertsil Prep-Sil column (25 x 2 i.d.; Gasukuro Kogyo) and Ultrasphere Si (25 x 1 i.d.; Beckman) to yield 6β-angeloyloxy-8α-hydroxyeremophil-1(10),7(11)-dien-8β,12-olide (13) (5.4 mg), 6β-angeloyloxy-8α-hydroxyeremophil-1(10),7(11)-dien-8β,12-olide (5) (1.8 mg) and 6β-isobutanoiloxy-8α-hydroxyeremophil-1(10),7(11)-dien-8β,12-olide (6) (5.0 mg). The structures of these compounds were determined by comparison of their spectroscopic data with that reported in the literature [11] [12] [13] .
Cell culture and reagents: Human cell lines, A549 (lung adenocarcinoma), H292 (squamous lung cancer), HCT116 (colorectal carcinoma), and DU145 (prostate cancer) were cultured in RPMI 1640 medium (Lonza Verviers), and MCF-7 (breast adenocarcinoma), HeLa (cervix adenocarcinoma) SK-MEL-5 (malignant melanoma), and HS5 (bone marrow stroma) were cultured in Dulbecco's modified Eagle's medium (DMEM) (Lonza Verviers), supplemented with 10% FBS, 100 U/mL penicillin, 100 U/mL streptomycin, and 2mM glutamine. All cells were grown at 37ºC in a humidified atmosphere with 5% CO2 and were in the logarithmic growth phase at the initiation of the experiments. All lines were obtained from LGC Promochem, SLU-ATCC (Barcelona, Spain).
Stock solutions of compounds were prepared in dimethyl sulfoxide and diluted in fresh medium containing 0.1% FBS before each experiment.
Proliferation assays: Growth inhibition was assessed by using the WST-1 assay (Roche, Mannheim) according to the manufacturer's protocol. Cells diluted in 100 µL/well of cell culture medium were plated in 96-well flat-bottom plates and allowed to attach for 24 hours at 37ºC/5% CO2. The number of cells per well used in these experiments were as follows: A549, HCT116, and HeLa, 3000 cells; MCF7, H292, SKMEL5, DU145 and HS5, 5000 cells. Test products were added to each well and incubated for another 72 hours. All experimental points were set up in six wells, and all experiments were repeated at least three times. Each value represents the mean of the experiments performed.
Statistical analysis:
The median inhibition concentration (IC50) values were calculated using GraphPad Prism 6.0 (GraphPad Software, Inc, La Jolla, CA), using nonlinear curve fitting.
